---
title: "Guanidine - Eaton-Lambert Syndrome"
sidebar: mydoc_sidebar
permalink: db00536-mesh-d015624-1.html
toc: false 
---


Path ID: `DB00536_MESH_D015624_1`
{% include image.html url="images/db00536-mesh-d015624-1.png" file="db00536-mesh-d015624-1.png" alt="db00536-mesh-d015624-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D019791">MESH:D019791 </a> | guanidine | Drug |
| <a href="https://identifiers.org/Pfam:PF03520">Pfam:PF03520 </a> | KCNQ voltage-gated potassium channel | GeneFamily |
| <a href="https://identifiers.org/GO:0007274">GO:0007274 </a> | neuromuscular synaptic transmission | BiologicalProcess |
| <a href="https://identifiers.org/HP:0003690">HP:0003690 </a> | Limb muscle weakness | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D015624">MESH:D015624 </a> | Eaton-Lambert syndrome | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Guanidine | DISRUPTS | Kcnq Voltage-Gated Potassium Channel |
| Kcnq Voltage-Gated Potassium Channel | POSITIVELY REGULATES | Neuromuscular Synaptic Transmission |
| Neuromuscular Synaptic Transmission | AFFECTS RISK FOR | Limb Muscle Weakness |
| Limb Muscle Weakness | MANIFESTATION OF | Eaton-Lambert Syndrome |
|---------|-----------|---------|

Comment: Guanidine is known to causes many side effects; therefore it's not recommended.

Reference: 
  - [https://go.drugbank.com/drugs/DB00536](https://go.drugbank.com/drugs/DB00536)
  - [https://en.wikipedia.org/wiki/Lambert%E2%80%93Eaton_myasthenic_syndrome#Other](https://en.wikipedia.org/wiki/Lambert%E2%80%93Eaton_myasthenic_syndrome#Other)
